Methyl 4-methyl-1H-benzo[d]imidazole-6-carboxylate (CAS 1132638-94-8) is a benzimidazole-based organic compound with the molecular formula C₁₀H₁₀N₂O₂ and a molecular weight of 190.20 g/mol, which serves as a key pharmaceutical and agrochemical research intermediate widely accessible via mainstream chemical distributors and custom synthesis platforms.
[Preparation Methods and Key Synthetic Routes of Methyl 4-methyl-1H-benzo[d]imidazole-6-carboxylate]
The target molecule is a 2-unsubstituted benzimidazole bearing a methyl ester at the 6-position and a methyl group at the 4-position. The core challenge is the construction of the imidazole ring with the correct regiochemistry of the substituents on the benzene ring.
2 Replies
-
Administrator Site Administrator
The Phillips Condensation (Route 1): This is the most direct and industrially preferred method. It involves the cyclocondensation of a substituted o-phenylenediamine with a one-carbon donor (formic acid or triethyl orthoformate).
Key Advantage: It forms the imidazole ring in a single step with high atom economy.
Critical Challenge: The starting material, methyl 3,4-diamino-5-methylbenzoate, is an unsymmetrical diamine. Cyclization with formic acid will produce a tautomeric mixture of 4-methyl and 6-methyl regioisomers because the imidazole N-H proton can tautomerize. To obtain a single isomer, the diamine must be synthesized with precise regiochemistry, or a temporary protecting group (e.g., a tosyl group) must be used on one amine to direct the cyclization, followed by deprotection. Despite this, it remains the most practical route due to the commercial availability of similar precursors. -
Administrator Site Administrator
The Oxidative Cyclization (Route 2): This route uses an o-nitroaniline and an aldehyde (formaldehyde), followed by reductive cyclization.
Key Advantage: The starting material (methyl 4-amino-3-nitro-5-methylbenzoate) is often more stable and easier to purify than the diamine.
Disadvantage: It requires an extra reduction step and the use of a reducing agent (e.g., sodium dithionite, SnCl₂, or catalytic hydrogenation). The reduction conditions must be mild to avoid hydrolyzing the methyl ester.
Transition Metal-Catalyzed C-H Activation: This is a modern approach that forms the imidazole ring via direct C-H functionalization of an aniline derivative.
Key Advantage: It avoids the need for a pre-installed second amino group, reducing synthetic steps.
Disadvantage: It requires expensive palladium or copper catalysts, ligands, and often harsh conditions, making it economically unviable for large-scale preparation and unsuitable for standard laboratory synthesis.